Arnaud Martino Capuzzo

Dr. Arnaud Martino Capuzzo

University of Milan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2021 in Preprints.org
Verified
Preprint
Open access
Arnaud Martino CapuzzoArnaud Martino Capuzzo
Arnaud Martino Capuzzo
On estimation scales ranging from 0.1 nm to 100 nm, the nanoscale is part of the capacitance components of the physical-synthetic and natural environment. Dimensionality, morphology, structure, uniformity, and agglomeration are all used to classify nanoparticles. Its functionality and effect on the environment and species are influenced by its shape and morphology. The priority research is to determine the effects of nanoparticles on any biological entity that is necessary when designing nanotechnology-based biotechnological and biomedical products. Bacteria have a remarkable ability to reduce metal ions, making them one of the most promising candidates for nanoparticle biosynthesis. Nanoparticles have been researched in the biomedical field for antimicrobial, biosensor, diagnostic imaging, and drug delivery applications. These natural technologies appear to be capable of producing stable nanoparticles with well-defined dimensions, morphologies, and compositions by optimizing reaction conditions and selecting the best bacteria. This work includes a list of the most commonly used microorganisms and associated Nanoparticles, as well as a discussion of current biotechnology and biomedical developments.

14 May 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
SQSameer Quazi
Sameer Quazi
JMJavid Ahmad Malik
Javid Ahmad Malik
KSKomal Singh Suman
Komal Singh Suman
Arnaud Martino CapuzzoArnaud Martino Capuzzo
Arnaud Martino Capuzzo
ZHZeshan Haider
Zeshan Haider
Marburg virus (MARV) has been confirmed to cause extreme hemorrhagic fever (HFM) in human and animals. The effective and suitable vaccine to treat the MARV virus is not commercialized in public and demands rigorously tested on several scales. This research used a CADD (Computer-Aided Drug Design) computational based technology to find novel drug-like compounds that could inhibit the replicating of the VP40. The pharmacophoric features bases screening was done using an online computational based software, “ZINC Pharmer”. We retrieved about 32456 compounds mainly focused on the properties of pharmacophores from the ZINC database. Lipinski’s rule was also used to predict these drug-like compounds. as well as molecular coupling-dependent screening and selection of VP40 screening ligand complexes based on S-rank (lower than reference) and value of root, mean square (RMSD) (bottom) to examine for reference) using the Molecular Working Environment (MOE) machine. As a result, 100 compounds were found to have a close interaction with MARV VP40, followed by the Binding energy (BE) analysis of these 100 compounds. Only 50 were the strongest binding energy than favipiravir [reference inhibitor] after using the MOE-LigX algorithm to compare their binding energy. After that, ADMET analysis predicted only five compounds (ZINC95457352, ZINC38752258, ZINC38752253, ZINC39272175, and ZINC38752377) passed the ADMET parameters and have the strongest inhibitory effect against the MARV’s VP40. It has been suggested that these “drug-like” candidates have an increased ability to inhibit MARV replication, leading to treatment of MARVD.

10 February 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
SQSameer Quazi
Sameer Quazi
JMJaved Malik
Javed Malik
Arnaud Martino CapuzzoArnaud Martino Capuzzo
Arnaud Martino Capuzzo
KSKamal Singh Suman
Kamal Singh Suman
ZHZeshan Haider
Zeshan Haider
The Marburg virus (MARV) is a highly etiological agent of hemorrhagic fever in humans. MARV has spread across the world, including America, Australia, Europe, and different Asia countries. However, there is no approved vaccine to combat MARV, combined with a high mortality rate, which makes antiviral drugs against MARV urgent. The viral protein (VP35) is a core protein of MARV that involves multiple functions of the infection cycle. This research used an in-silico drug design technique to discover the new drug-like small molecules that inhibit VP35 replication. First, several combinations of ∼ 4260 showed that structure-based similarity above 90% was retrieved from an online “PubChem” database. Molecular docking was performed using AutoDock 4.2, and ligands were selected based on docking / S score lower than reference CID_5477931 and RMSD value between 1-2. Finally, about 50 compounds showed greater bonding producing hydrogen, Van der Waals, and polar interactions with VP35. After evaluating their binding energy strength and ADMET analysis, only CID_ 3007938 and CID_11427396 were finalized, which showed the most vital binding energy and a strong inhibitory effect with MARV’s VP35. The higher binding energy, suitable ADMET, and drug similarity parameters suggest that these “CID_ 3007938 and CID_11427396” candidates have incredible latency to inhibit MARV replication; hence, these strengths led to the treatment of MAVD.

Verified
Journal Article
Open access
PDF file
Arnaud Martino CapuzzoArnaud Martino Capuzzo
Arnaud Martino Capuzzo
GPGiusi Piccolantonio
Giusi Piccolantonio
Alessandro NegriAlessandro Negri
Alessandro Negri
PBPietro Bontempi
Pietro Bontempi
MLMaria A. Lacavalla
Maria A. Lacavalla
PMPasquina Marzola
Pasquina Marzola
Adipose tissue-derived adult stem (ADAS) cells and extracellular vesicle (EV) therapy offer promising avenues for treating neurodegenerative diseases due to their accessibility and potential for autologous cell transplantation. However, the clinical application of ADAS cells or EVs is limited by the challenge of precisely identifying them in specific regions of interest. This study compares two superparamagnetic iron oxide nanoparticles, differing mainly in size, to determine their efficacy for allowing non-invasive ADAS tracking via MRI/MPI and indirect labeling of EVs. We compared a USPIO (about 5 nm) with an SPIO (Resovist®, about 70 nm). A physicochemical characterization of nanoparticles was conducted using DLS, TEM, MRI, and MPI. ADAS cells were labeled with the two nanoparticles, and their viability was assessed via MTT assay. MRI detected labeled cells, while TEM and Prussian Blue staining were employed to confirm cell uptake. The results revealed that Resovist® exhibited higher transversal relaxivity value than USPIO and, consequently, allows for detection with higher sensitivity by MRI. A 200 µgFe/mL concentration was identified as optimal for ADAS labeling. MPI detected only Resovist®. The findings suggest that Resovist® may offer enhanced detection of ADAS cells and EVs, making it suitable for multimodal imaging. Preliminary results obtained by extracting EVs from ADAS cells labeled with Resovist® indicate that EVs retain the nanoparticles, paving the way to an efficient and multimodal detection of EVs.

21 June 2023
Verified
Book Chapter
Open access
PDF file
Arnaud Martino CapuzzoArnaud Martino Capuzzo
Arnaud Martino Capuzzo
RORiccardo Ossanna
Riccardo Ossanna
LSLindsey Alejandra Quintero Sierra
Lindsey Alejandra Quintero Sierra
FVFederica Virla
Federica Virla
ANAlessandro Negri
Alessandro Negri
SVSheila Veronese
Sheila Veronese
Regenerative medicine aims to repair organs or tissues that have congenital abnormalities, or that have been damaged by disease, aging, or trauma, and to restore or at least improve their native function. One of the strategies used in regenerative medicine is stem cell therapy, due to the enormous regenerative potential of stem cells. A staminal cell line is a group of cells that can replicate for an extended period in vitro, that is outside the body. These cells are grown in incubators using a culture medium that should have a temperature and an oxygen/carbon dioxide composition that simulates the desired environment. This chapter describes the main characteristics of stem cells, the main fields of application, and outlines what could be the future developments of their use, also considering the ethical and technical problems that currently limit their use. There is still much to be done in the field of stem cell research, and researchers are working tirelessly to remain leaders and innovators in it. A struggle, step by step, will make it possible to have more information on current knowledge by expanding the scientific literature and push current limits ever further.

1 November 2020 in International Journal of Engineering Applied Sciences and Technology
Verified
Journal Article
Closed access
Arnaud Martino CapuzzoArnaud Martino Capuzzo
Arnaud Martino Capuzzo
DVDaniele Vigo
Daniele Vigo
This paper carries outthe implementation of a Raspberry-controlled bioreactor. The previously proposed model was analyzed and assembled to determine its effectiveness and solutions to the problems that emerged during construction were highlighted. The realization of the project is possible, as now some elements can be replaced. Overall, these modifications on this miniature rotary bioreactor make the apparatus exceptionally easy to build following designated guidelines. This updated device is susceptible to various experiments of varying lengths without having to worry about possible malfunctions such as unexpected events or hardware and software problems.